| [1] |
Torre LA，Bray F，Siegel RL，et al.Global cancer statistics，2012[J].CA Cancer J Clin，2015，65（2）：87-108.
|
| [2] |
Nelson ER.The significance of cholesterol and its metabolite，27-hydroxycholesterol in breast cancer[J].Mol Cell Endocrinol，2018，466：73-80.
|
| [3] |
Melvin JC，Holmberg L，Rohrmann S，et al.Serum lipid profiles and cancer risk in the context of obesity：Four Metaanalyses[J].J Cancer Epidemiol，2013，2013：823-849.
|
| [4] |
Nelson ER，Chang CY，McDonnell DP.Cholesterol and breast cancer pathophysiology[J].Trends Endocrinol Metab，2014，25（12）：649-655.
|
| [5] |
Hu J，La Vecchia C，de Groh M，et al.Dietary cholesterol intake and cancer[J].Ann Oncol，2012，23（2）：491-500.
|
| [6] |
Danilo C，Frank PG.Cholesterol and breast cancer development[J].Curr Opin Pharmacol，2012，12（6）：677-682.
|
| [12] |
Murai T.Cholesterol lowering：role in cancer prevention and treatment[J].Biol Chem，2015，396（1）：1-11.
|
| [7] |
Kucharska-Newton AM，Rosamond WD，Mink PJ，et al.HDLcholesterol and incidence of breast cancer in the ARIC cohort study[J].Ann Epidemiol，2008，18（9）：671-677.
|
| [8] |
Ha M，Sung J，Song YM.Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women[J].Cancer Causes Control，2009，20（7）：1055-1060.
|
| [9] |
Kitahara CM，Berrington de González A，Freedman ND，et al.Total cholesterol and cancer risk in a large prospective study in Korea[J].J Clin Oncol，2011，29（12）：1592-1598.
|
| [10] |
Gupta RK，Patel AK，Kumari R，et al.Interactions between oxidative stress，lipid profile and antioxidants in breast cancer：a case control study[J].Asian Pac J Cancer Prev，2012，13（12）：6295-6298.
|
| [11] |
Li C，Yang L，Zhang D，Jiang W.Systematic review and meta-analysis suggest that dietary cholesterol intake increases risk of breast cancer[J].Nutr Res，2016，36（7）：627-635.
|
| [13] |
Llaverias G，Danilo C，Mercier I，et al.Role of cholesterol in the development and progression of breast cancer[J].Am J Pathol，2011，178（1）：402-412.
|
| [14] |
Pfefferle AD，Herschkowitz JI，Usary J，et al.Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts[J].Genome Biol，2013，14（11）：R125.
|
| [15] |
Alikhani N，Ferguson RD，Novosyadlyy R，et al.Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model[J].Oncogene，2013，32（8）：961-967.
|
| [16] |
Nelson ER，Wardell SE，Jasper JS，et al.27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology[J].Science，2013，342（6162）：1094-1098.
|
| [17] |
Llaverias G，Escolà-Gil JC，Lerma E，et al.Phytosterols inhibit the tumor growth and lipoprotein oxidizability induced by a high-fat diet in mice with inherited breast cancer[J].J Nutr Biochem，2013，24（1）：39-48.
|
| [18] |
He S，Nelson ER.27-Hydroxycholesterol，an endogenous selective estrogen receptor modulator[J].Maturitas，2017，104：29-35.
|
| [19] |
Capasso I，Esposito E，Pentimalli F，et al.Metabolic syndrome affects breast cancer risk in postmenopausal women：National Cancer Institute of Naples experience[J].Cancer Biol Ther，2010，10（12）：1240-1243.
|
| [20] |
Marwarha G，Raza S，Hammer K，et al.27-hydroxycholesterol：A novel player in molecular carcinogenesis of breast and prostate cancer[J].Chem Phys Lipids，2017，207（Pt B）：108-126.
|
| [21] |
Bovenga F，Sabbà C，Moschetta A.Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer[J].Cell Metab，2015，21（4）：517-526.
|
| [22] |
Wu Q，Ishikawa T，Sirianni R，et al.27-Hydroxycholesterol promotes cell-autonomous，ER-positive breast cancer growth[J].Cell Rep，2013，5（3）：637-645.
|
| [23] |
Gazzerro P，Proto MC，Gangemi G，et al.Pharmacological actions of statins：a critical appraisal in the management of cancer[J].Pharmacol Rev，2012，64（1）：102-146.
|
| [24] |
Islam MM，Yang HC，Nguyen PA，et al.Exploring association between statin use and breast cancer risk：an updated meta-analysis[J].Arch Gynecol Obstet，2017，296（6）：1043-1053.
|
| [25] |
Undela K，Srikanth V，Bansal D.Statin use and risk of breast cancer：a meta-analysis of observational studies[J].Breast Cancer Res Treat，2012，135（1）：261-269.
|
| [26] |
Ahern TP，Pedersen L，Tarp M，et al.Statin prescriptions and breast cancer recurrence risk：a Danish nationwide prospective cohort study[J].J Natl Cancer Inst，2011，103（19）：1461-1468.
|
| [27] |
Kwan ML，Habel LA，Flick ED，et al.Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors[J].Breast Cancer Res Treat，2008，109（3）：573-579.
|
| [28] |
Sakellakis M，Akinosoglou K，Kostaki A，et al.Statins and risk of breast cancer recurrence[J].Breast Cancer（Dove Med Press），2016，8：199-205.
|
| [29] |
Chae YK，Valsecchi ME，Kim J，et al.Reduced risk of breast cancer recurrence in patients using ACE inhibitors，ARBs，and/or statins[J].Cancer Invest，2011，29（9）：585-593.
|
| [30] |
Bjarnadottir O，Romero Q，Bendahl PO，et al.Targeting HMGCoA reductase with statins in a window-of-opportunity breast cancer tria[J].Breast Cancer Res Treat，2013，138（2）：499-508.
|
| [31] |
Shaitelman SF，Stauder MC，Allen P，et al.Impact of Statin Use on Outcomes in Triple Negative Breast Cancer[J].J Cancer，2017，8（11）：2026-2032.
|
| [32] |
Denoyelle C，Vasse M，Korner M，et al.Cerivastatin，an inhibitor of HMG-CoA reductase，inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines：an in vitro study[J].Carcinogenesis，2001，22（8）：1139-1148.
|
| [40] |
Rogers TL，Holen I.Tumour macrophages as potential targets of bisphosphonates[J].J Transl Med，2011，9：177.
|
| [33] |
Mast N，Lin JB，Pikuleva IA.Marketed Drugs Can Inhibit Cytochrome P450 27A1，a Potential New Target for Breast Cancer Adjuvant Therapy[J].Mol Pharmacol，2015，88（3）：428-436.
|
| [34] |
Wu Y，Yu DD，Yan DL，et al.Liver X receptor as a drug target for the treatment of breast cancer[J].Anticancer Drugs，2016，27（5）：373-382.
|
| [35] |
Elangovan S，Pathania R，Ramachandran S，et al.The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival[J].Cancer Res，2014，74（4）：1166-1178.
|
| [36] |
Lukasova M，Malaval C，Gille A，et al.Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells[J].J Clin Invest，2011，121（3）：1163-1173.
|
| [37] |
Vini R，Juberiya AM，Sreeja S.Evidence of pomegranate methanolic extract in antagonizing the endogenous SERM，27-hydroxycholesterol[J].IUBMB Life，2016，68（2）：116-121.
|
| [38] |
Samavat H，Newman AR，Wang R，et al.Effects of green tea catechin extract on serum lipids in postmenopausal women：a randomized，placebo-controlled clinical trial[J].Am J Clin Nutr，2016，104（6）：1671-1682.
|
| [39] |
Young RJ，Coleman RE.Zoledronic acid to prevent and treat cancer metastasis：new prospects for an old drug[J].Future Oncol，2013，9（5）：633-643.
|
| [41] |
McDonnell DP，Park S，Goulet MT，et al.Obesity，cholesterol metabolism，and breast cancer pathogenesis[J].Cancer Res，2014，74（18）：4976-4982.
|
